Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GP vs TPF Induction Chemotherapy in Locally Advanced NPC
NCT02016417Phase 2Unknown
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Start
- May 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of gemcitabine in nasopharyngeal carcinoma (NPC), sponsored by Cancer Hospital of Guangxi Medical University. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02016417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016417.